Ethical considerations for pharmacogenomic testing in pediatric clinical care and research

Author： Moran Cassandra Thornburg Courtney D Barfield Raymond C

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.6, 2011-06, pp. : 889-895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ethical Considerations in Conducting Pediatric and Neonatal Research in Clinical Pharmacology

Current Pharmaceutical Design, Vol. 21, Iss. 39, 2015-12 ,pp. : 5619-5635

Bentham Science Publishers

Access to resources Recommend Favorite

Ethical considerations in clinical pharmacogenomics research

By Issa A.M.

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 247-249

Elsevier

Access to resources Recommend Favorite

Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin

By Shahabi Payman Siest Gérard Visvikis-Siest Sophie

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1215-1218

Future Medicine

Access to resources Recommend Favorite

Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 2, 2011-06 ,pp. : 94-101

Bentham Science Publishers

Access to resources Recommend Favorite

Ethical Considerations in Clinical Trials

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 2-4

Karger

Access to resources Recommend Favorite